Public Employees Retirement Association of Colorado Sells 2,634 Shares of Danaher Co. (NYSE:DHR)

Public Employees Retirement Association of Colorado decreased its position in Danaher Co. (NYSE:DHR) by 0.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 583,732 shares of the conglomerate’s stock after selling 2,634 shares during the quarter. Public Employees Retirement Association of Colorado owned approximately 0.08% of Danaher worth $145,845,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in DHR. Cape Investment Advisory Inc. bought a new position in Danaher during the fourth quarter valued at about $25,000. Tsfg LLC boosted its position in Danaher by 733.3% during the first quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 88 shares during the period. CarsonAllaria Wealth Management Ltd. bought a new position in Danaher during the second quarter worth about $25,000. nVerses Capital LLC bought a new position in Danaher during the second quarter worth about $25,000. Finally, Redmont Wealth Advisors LLC bought a new position in Danaher during the first quarter worth about $30,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on DHR. Royal Bank of Canada reiterated an “outperform” rating and set a $300.00 target price on shares of Danaher in a research report on Friday, September 6th. Barclays increased their target price on shares of Danaher from $270.00 to $285.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 24th. Robert W. Baird increased their target price on shares of Danaher from $271.00 to $278.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Jefferies Financial Group initiated coverage on shares of Danaher in a report on Monday, June 3rd. They issued a “buy” rating and a $295.00 price target on the stock. Finally, Leerink Partners increased their price target on shares of Danaher from $275.00 to $280.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Seven research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $278.94.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 9,600 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $275.16, for a total value of $2,641,536.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $5,566,486.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO Rainer Blair sold 9,007 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $280.00, for a total value of $2,521,960.00. Following the transaction, the chief executive officer now owns 97,983 shares in the company, valued at $27,435,240. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Brian W. Ellis sold 9,600 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $275.16, for a total transaction of $2,641,536.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $5,566,486.80. The disclosure for this sale can be found here. Insiders have sold 39,659 shares of company stock worth $11,042,433 over the last ninety days. Insiders own 11.10% of the company’s stock.

Danaher Trading Up 1.7 %

Shares of DHR opened at $276.43 on Friday. The firm’s 50 day simple moving average is $267.10 and its 200 day simple moving average is $257.03. The company has a market capitalization of $204.75 billion, a P/E ratio of 46.85, a P/E/G ratio of 4.48 and a beta of 0.83. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.04. Danaher Co. has a 1-year low of $182.09 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.15. The business had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.94% and a return on equity of 11.06%. Danaher’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period last year, the firm posted $2.05 earnings per share. Sell-side analysts forecast that Danaher Co. will post 7.59 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Friday, September 27th will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date of this dividend is Friday, September 27th. Danaher’s payout ratio is currently 18.31%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.